NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.780
-0.200 (-10.10%)
Nov 11, 2026, 4:00 PM EST - Market closed
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $3.29 million as of November 11, 2026. It is the 46,389th most valuable company in the world and the 6,138th biggest in the United States. Its market cap has decreased by 86.10% in one year.
Market Cap
3.29M
Enterprise Value
3.29M
1-Year Change
-86.10%
Global Rank
Country Rank
#6,138 United States
Category
ChartMarket Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $3.29M, a decrease of -94.91%. That is a compound annual growth rate of -45.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 3.29M | -85.59% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Imunon | 4.04M |
| GRI Bio | 4.00M |
| Liminatus Pharma | 3.95M |
| Traws Pharma | 3.84M |
| Azitra | 3.55M |
| Silo Pharma | 3.45M |
| KALA BIO | 3.31M |
| Mustang Bio | 3.24M |